Personal information

Emails & domains

Verified email domains

Other IDs

Loop profile: 416917
SciProfiles: 2055642

Activities

Collapse all

Employment (5)

INSERM: STRASBOURG, FR

2023-05-25 to present | Junior group leader (U1118)
Employment
Source: Self-asserted source
Wenting Guo

KU Leuven: Leuven, Flemish Brabant, BE

2022-06-01 to 2022-12-31 | Postdoc researcher (Department of Chemistry)
Employment
Source: Self-asserted source
Wenting Guo

VIB KU Leuven Center for Brain & Disease Research: Leuven, BE

2017-10 to 2022-12-31 | Postdoctral scientist
Employment
Source: Self-asserted source
Wenting Guo

KU Leuven: Leuven, BE

2017-10-01 to 2022-12-31 | Postdoctoral researcher (Stem Cell and Developmental Biology)
Employment
Source: Self-asserted source
Wenting Guo

Katholieke Universiteit Leuven: Leuven, Vlaanderen, BE

2013-10-01 to 2017-10-01 | PhD researcher (Department of neuroscience)
Employment
Source: Self-asserted source
Wenting Guo

Education and qualifications (3)

KU Leuven: Leuven, BE

2013-10-01 to 2017-10-04 | PhD in Biomedical sciences (Department of Neurosciences)
Qualification
Source: Self-asserted source
Wenting Guo

Shanghai Jiao Tong University: Shanghai, CN

2010-09-01 to 2013-07-01 | MSc in Genetics
Education
Source: Self-asserted source
Wenting Guo

Shanxi University: Taiyuan, Shanxi, CN

2006-09-01 to 2010-07-01 | BS in Biology; BA in English Language and Literature
Education
Source: Self-asserted source
Wenting Guo

Professional activities (10)

International Society for Stem Cell Research: Skokie, IL, US

Membership
Source: Self-asserted source
Wenting Guo

Belgian Society for Stem Cell Research (BeSSCR): Brussels, BE

Membership
Source: Self-asserted source
Wenting Guo

Belgian Society for Cell and Developmental Biology (BSCDB): Brussels, BE

Membership
Source: Self-asserted source
Wenting Guo

BioMed Central Ltd: London, London, GB

2022-02 to present | Editorial board member
Service
Source: Self-asserted source
Wenting Guo

Journal of Clinical Medicine : Basel, CH

2022 to present | Reviewer board
Service
Source: Self-asserted source
Wenting Guo

The International Consortium for Personalised Medicine: Milan, IT

2021 to present | External expert for "Integrating China in the International Consortium for Personalized Medicine" initiative (IC2PerMed)
Service
Source: Self-asserted source
Wenting Guo

Sino-European Health Networking Hub (SENET): Stuttgart, DE

2021 to present | External expert for panel discussion
Service
Source: Self-asserted source
Wenting Guo

Frontiers in Molecular Neuroscience : lausanne, CH

2020 to present | Guest Associate Editor of the special topic: Current Concept and Translational Study in ALS–FTD Spectrum: from Genetics, Neuroinflammation to Neurodegeneration
Service
Source: Self-asserted source
Wenting Guo

European Advanced Translational Research Infrastructure in Medicine: Amsterdam, NL

2020 | Best of EATRIS (European Advanced Translational Research Infrastructure in Medicine) Five Challenges
Distinction
Source: Self-asserted source
Wenting Guo

Zhejiang University: Hangzhou, CN

2017 | Excellent oral presentation award of 1st International Doctoral Student Conference
Distinction
Source: Self-asserted source
Wenting Guo

Funding (5)

CRISPR / Cas9 screen in human stem cell-derived neurons to identify pharmacological targets for amyotrophic lateral sclerosis (ALS)

2019-01 to 2019-12 | Grant
Fonds Wetenschappelijk Onderzoek (brussels, BE)
Source: Self-asserted source
Wenting Guo

Pooled CRISPR/Cas9 screen in human stem cell-derived motor neurons to identify new therapeutic targets for amyotrophic lateral sclerosis (ALS)

2018-10 to 2019-10 | Salary award
KU Leuven (Leuven, BE)
Source: Self-asserted source
Wenting Guo

CRISPR/Cas9 technology for generation of isogenic control lines of iPSCs derived from ALS patients with different FUS point mutations

2015-03 to 2015-09 | Grant
Flanders Interuniversity Institute for Biotechnology (Ghent, BE)
Source: Self-asserted source
Wenting Guo

Pooled kinome wide CRISPR/Cas9 screen in human stem cell-derived neurons to identify pharmacological targets for ALS/FTD

Award
International Society for Stem Cell Research (Skokie, Illinois, US)
Source: Self-asserted source
Wenting Guo

Pooled kinome wide CRISPR/Cas9 screen in human stem cell-derived neurons to identify pharmacological targets for ALS/FTD

Award
Belgian Society for Stem Cell Research (BeSSCR) (Brussels, BE)
Source: Self-asserted source
Wenting Guo

Peer review (2 reviews for 2 publications/grants)

Review activity for Journal of neurology, neurosurgery and psychiatry (1)
Review activity for Nature chemical biology. (1)
How many people are using ORCID?